BridgeMD
Treatment with Risedronate for dilated cardiomyopathy due to Troponin T alteration due to K210 deletion.
EU CTIS ID: 2023-509431-29-00
What this study is testing
To study whether the administration of Risedronate 10 mg/day in patients with dilated cardiomyopathy due to K210 deletion mutation in the Troponin T gene is associated with: A change in left ventricular function, measured by Echocardiogram
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Older than 18 years old
- Dilated cardiomyopathy due to K210 deletion mutation in the Troponin T gene
- LVEF ≤ 50%
- Patients who have given written informed consent
You likely can't join if
- Hypersensitivity to Risedronate
- Hypocalcemia
- Severe renal failure (eGFR < 30 ml/min/1.73m2)
- History of esophageal disorders, with delay in transit or esophageal emptying, due to example, stenosis or achalasia
- Barrett's esophagus
- Inability to remain upright for at least 30 minutes after taking of the tablet.
See the full eligibility criteria
- Older than 18 years old
- Dilated cardiomyopathy due to K210 deletion mutation in the Troponin T gene
- LVEF ≤ 50%
- Patients who have given written informed consent
- Hypersensitivity to Risedronate
- Hypocalcemia
- Severe renal failure (eGFR < 30 ml/min/1.73m2)
- History of esophageal disorders, with delay in transit or esophageal emptying, due to example, stenosis or achalasia
- Barrett's esophagus
- Inability to remain upright for at least 30 minutes after taking of the tablet.
- Active treatment with corticosteroids or chemotherapy
- Pregnant or breastfeeding women
- Use of other investigational drugs at the time of inclusion, or during the 30 days prior to inclusion
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.